Bio-AMD, Inc. is engaged in the developing of point of care (POC) medical diagnostic reader device business and developing its currency risk mitigation business. Bio-AMD is a technology focused in the POC medical diagnostic reader market. Bio-AMD has three technologies namely digital strip reader (DSR), coagulation device (COAG) and magnetic particle reader (MPR). DSR performs a range of POC assay tests for infectious diseases, drugs of abuse, cardiology, oncology, cholesterol and the female well-being market (pregnancy, fertility and menopause). COAG is a micro-fluidic strip technology for use in POC hand-held device to detect prothrombin time (PT)/International Normalized Ratio (INR) or the coagulation of blood. COAG is also used for testing oral anticoagulation therapy. MPR provides measurement through the application of micro-fluidics and lab-on-chip technology.